XML 55 R43.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock and Incentive Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Black-Scholes Option Pricing Model
The table below includes the weighted-average assumptions used to calculate the grant date fair value of the ESPP rights for the periods indicated using the Black-Scholes option pricing model:
Years Ended December 31,
202320222021
Expected term (in years)1.001.001.00
Dividend yield$1.88 $1.41 $1.25 
Risk-free interest rate3.90 %1.24 %0.10 %
Expected volatility31.63 37.90 45.96 
Schedule of ESPP Shares Purchased
The ESPP shares purchased are as follows for the dates indicated:
Years Ended December 31,
202320222021
ESPP shares purchased46,213 26,089 — 
Shares available for issuance under the ESPP927,698 973,911 1,000,000 
Schedule of Share-Based Compensation Cost Charged to Income
Share-based compensation cost charged to income for the years ended December 31, 2023, 2022 and 2021, is presented below. There was no stock option expense for any of the periods shown.
Years Ended December 31,
(Dollars in thousands)202320222021
RSA & RSU$4,321 $2,845 $2,100 
PSU534 288 — 
ESPP426 316 195 
Total stock compensation expense$5,281 $3,449 $2,295 
Related tax benefits recognized in net income$1,109 $724 $482 
Schedule of Time-Vested Award Activity
The following table summarizes the Company’s award activity:
Years Ended December 31,
202320222021
SharesWeighted Average Grant-Date Fair ValueSharesWeighted Average Grant-Date Fair ValueSharesWeighted Average Grant-Date Fair Value
Nonvested RSAs, January 1,27,391 $35.37 48,048 $35.27 103,359 $31.51 
Granted RSAs16,788 28.61 12,840 37.39 13,460 42.26 
Vested RSAs(26,550)35.11 (33,497)36.00 (67,825)31.07 
Forfeited RSAs— — — — (946)24.69 
Nonvested RSAs, December 31,
17,629 29.33 27,391 35.37 48,048 35.27 
Nonvested RSUs, January 1,270,390 $39.63 73,977 $40.64 — $— 
Granted RSUs116,098 35.65 222,282 39.43 73,977 40.64 
Vested RSUs(55,614)41.98 (24,028)40.56 — — 
Forfeited RSUs(12,706)41.59 (1,841)43.48 — — 
Nonvested RSUs, December 31,
318,168 37.69 270,390 39.63 73,977 40.64 
Nonvested PSUs, January 1,157,367 $29.06 — $— — $— 
Granted PSUs43,591 31.77 157,367 29.06 — — 
Forfeited PSUs(3,116)31.77 — — — — 
Nonvested PSUs, December 31,
197,842 28.33 157,367 29.06 — — 
Schedule of Stock Option Activity
The table below summarizes the status of the Company’s stock options and changes during the years ended December 31, 2023, 2022, and 2021.
(Dollars in thousands, except per share amounts)Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual Term (in years)Aggregate Intrinsic Value
Year Ended December 31, 2023
Outstanding at January 1, 2023504,437 $29.46 5.13$3,736 
Exercised(135,746)23.61 — 1,533 
Expired(15,218)34.48 — — 
Outstanding and exercisable at December 31, 2023
353,473 31.49 4.461,670 
Year Ended December 31, 2022
Outstanding at January 1, 202239,200 $10.73 2.28$1,262 
BTH options converted to OBK options611,676 28.62 — 8,838 
Exercised(144,785)20.80 — 2,992 
Expired(1,654)34.44 — — 
Outstanding and exercisable at December 31, 2022
504,437 29.46 5.133,736 
Year Ended December 31, 2021
Outstanding at January 1, 2021224,000 $10.86 4.92$3,789 
Exercised(184,800)10.88 — 6,447 
Outstanding and exercisable at December 31, 2021
39,200 10.73 2.281,262 
Schedule of Compensation Expense
Compensation expense for the CEO PSUs will be recognized over the vesting period of the awards based on the fair value of the award at the grant date determined by using a Monte Carlo simulation model with the following inputs:
Simulation InputsYear Ended December 31, 2022
Grant dateDecember 13, 2022
Performance periodseven years
Stock price$36.87 
Expected volatility (1)
33.0 %
Risk-free rate (2)
3.5 
____________________________
(1)The expected volatility was determined based on the historical volatilities of the Company and the specified peer group.
(2)The risk-free interest rate for the performance period was derived from the seven-year continuous U.S. Treasury Yield constant maturity curve on the valuation date.